The role of miRNA200a as biomarker to detect breast and ovarian cancers in Iraqi women. Journal of Pharmaceutical Negative Results, [S. l.], v. 13, n. 4, p. 463–467, 2022. DOI: 10.47750/pnr.2022.13.04.059. Disponível em: https://mail.pnrjournal.com/index.php/home/article/view/1488.. Acesso em: 9 jun. 2026.